|
1 Indications And Usage Daliresp ® Is Indicated As A Treatment To Reduce The Risk Of Copd Exacerbations In Patients With Severe Copd Associated With Chronic Bronchitis And A History Of Exacerbations. Daliresp Is A Selective Phosphodiesterase 4 Inhibitor Indicated As A Treatment To Reduce The Risk Of Copd Exacerbations In Patients With Severe Copd Associated With Chronic Bronchitis And A History Of Exacerbations. ( 1 , 14 ) Limitations Of Use : • Daliresp Is Not A Bronchodilator And Is Not Indicated For The Relief Of Acute Bronchospasm. ( 1, 14 ) • Daliresp 250 Mcg Is A Starting Dose, For The First 4 Weeks Of Treatment Only And Is Not The Effective (Therapeutic) Dose. ( 2, 14 ) Limitations Of Use Daliresp Is Not A Bronchodilator And Is Not Indicated For The Relief Of Acute Bronchospasm. Daliresp 250 Mcg Is A Starting Dose, For The First 4 Weeks Of Treatment Only And Is Not The Effective (Therapeutic) Dose.
|